Aranesp

Negara: Uni Eropa

Bahasa: Inggris

Sumber: EMA (European Medicines Agency)

Beli Sekarang

Selebaran informasi Selebaran informasi (PIL)
11-11-2022
Karakteristik produk Karakteristik produk (SPC)
11-11-2022

Bahan aktif:

darbepoetin alfa

Tersedia dari:

Amgen Europe B.V.

Kode ATC:

B03XA02

INN (Nama Internasional):

darbepoetin alfa

Kelompok Terapi:

Other antianemic preparations

Area terapi:

Anemia; Cancer; Kidney Failure, Chronic

Indikasi Terapi:

Treatment of symptomatic anaemia associated with chronic renal failure (CRF) in adults and paediatric patients.Treatment of symptomatic anaemia in adult cancer patients with non-myeloid malignancies receiving chemotherapy.

Ringkasan produk:

Revision: 45

Status otorisasi:

Authorised

Tanggal Otorisasi:

2001-06-08

Selebaran informasi

                                191
B. PACKAGE LEAFLET
192
PACKAGE LEAFLET: INFORMATION FOR THE USER
ARANESP 10 MICROGRAMS SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE
ARANESP 15 MICROGRAMS SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE
ARANESP 20 MICROGRAMS SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE
ARANESP 30 MICROGRAMS SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE
ARANESP 40 MICROGRAMS SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE
ARANESP 50 MICROGRAMS SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE
ARANESP 60 MICROGRAMS SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE
ARANESP 80 MICROGRAMS SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE
ARANESP 100 MICROGRAMS SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE
ARANESP 130 MICROGRAMS SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE
ARANESP 150 MICROGRAMS SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE
ARANESP 300 MICROGRAMS SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE
ARANESP 500 MICROGRAMS SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE
darbepoetin alfa
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor, pharmacist or
nurse.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.
-
If you get any side effects, talk to your doctor, pharmacist or nurse.
This includes any possible
side effects not listed in this leaflet (see section 4).
WHAT IS IN THIS LEAFLET
1.
What Aranesp is and what it is used for
2.
What you need to know before you use Aranesp
3.
How to use Aranesp
4.
Possible side effects
5.
How to store Aranesp
6.
Contents of the pack and other information
7.
Instructions for injecting with the Aranesp pre-filled syringe
1.
WHAT ARANESP IS AND WHAT IT IS USED FOR
Your doctor has given you Aranesp (an anti-anaemic) to treat your
anaemia. Anaemia is when your
blood does not contain enough red blood cells and the symptoms may be
fatigue, weakness and
                                
                                Baca dokumen lengkapnya
                                
                            

Karakteristik produk

                                1
ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
2
1.
NAME OF THE MEDICINAL PRODUCT
Aranesp 10 micrograms solution for injection in pre-filled syringe.
Aranesp 15 micrograms solution for injection in pre-filled syringe.
Aranesp 20 micrograms solution for injection in pre-filled syringe.
Aranesp 30 micrograms solution for injection in pre-filled syringe.
Aranesp 40 micrograms solution for injection in pre-filled syringe.
Aranesp 50 micrograms solution for injection in pre-filled syringe.
Aranesp 60 micrograms solution for injection in pre-filled syringe.
Aranesp 80 micrograms solution for injection in pre-filled syringe.
Aranesp 100 micrograms solution for injection in pre-filled syringe.
Aranesp 130 micrograms solution for injection in pre-filled syringe.
Aranesp 150 micrograms solution for injection in pre-filled syringe.
Aranesp 300 micrograms solution for injection in pre-filled syringe.
Aranesp 500 micrograms solution for injection in pre-filled syringe.
Aranesp 10 micrograms solution for injection in pre-filled pen.
Aranesp 15 micrograms solution for injection in pre-filled pen.
Aranesp 20 micrograms solution for injection in pre-filled pen.
Aranesp 30 micrograms solution for injection in pre-filled pen.
Aranesp 40 micrograms solution for injection in pre-filled pen.
Aranesp 50 micrograms solution for injection in pre-filled pen.
Aranesp 60 micrograms solution for injection in pre-filled pen.
Aranesp 80 micrograms solution for injection in pre-filled pen.
Aranesp 100 micrograms solution for injection in pre-filled pen.
Aranesp 130 micrograms solution for injection in pre-filled pen.
Aranesp 150 micrograms solution for injection in pre-filled pen.
Aranesp 300 micrograms solution for injection in pre-filled pen.
Aranesp 500 micrograms solution for injection in pre-filled pen.
Aranesp 25 micrograms solution for injection in vial.
Aranesp 40 micrograms solution for injection in vial.
Aranesp 60 micrograms solution for injection in vial.
Aranesp 100 micrograms solution for injection in vial.
Aranesp 200 micrograms so
                                
                                Baca dokumen lengkapnya
                                
                            

Dokumen dalam bahasa lain

Selebaran informasi Selebaran informasi Bulgar 11-11-2022
Karakteristik produk Karakteristik produk Bulgar 11-11-2022
Laporan Penilaian publik Laporan Penilaian publik Bulgar 14-05-2019
Selebaran informasi Selebaran informasi Spanyol 11-11-2022
Karakteristik produk Karakteristik produk Spanyol 11-11-2022
Laporan Penilaian publik Laporan Penilaian publik Spanyol 14-05-2019
Selebaran informasi Selebaran informasi Cheska 11-11-2022
Karakteristik produk Karakteristik produk Cheska 11-11-2022
Laporan Penilaian publik Laporan Penilaian publik Cheska 14-05-2019
Selebaran informasi Selebaran informasi Dansk 11-11-2022
Karakteristik produk Karakteristik produk Dansk 11-11-2022
Laporan Penilaian publik Laporan Penilaian publik Dansk 14-05-2019
Selebaran informasi Selebaran informasi Jerman 11-11-2022
Karakteristik produk Karakteristik produk Jerman 11-11-2022
Laporan Penilaian publik Laporan Penilaian publik Jerman 14-05-2019
Selebaran informasi Selebaran informasi Esti 11-11-2022
Karakteristik produk Karakteristik produk Esti 11-11-2022
Laporan Penilaian publik Laporan Penilaian publik Esti 14-05-2019
Selebaran informasi Selebaran informasi Yunani 11-11-2022
Karakteristik produk Karakteristik produk Yunani 11-11-2022
Laporan Penilaian publik Laporan Penilaian publik Yunani 14-05-2019
Selebaran informasi Selebaran informasi Prancis 11-11-2022
Karakteristik produk Karakteristik produk Prancis 11-11-2022
Laporan Penilaian publik Laporan Penilaian publik Prancis 14-05-2019
Selebaran informasi Selebaran informasi Italia 11-11-2022
Karakteristik produk Karakteristik produk Italia 11-11-2022
Laporan Penilaian publik Laporan Penilaian publik Italia 14-05-2019
Selebaran informasi Selebaran informasi Latvi 11-11-2022
Karakteristik produk Karakteristik produk Latvi 11-11-2022
Laporan Penilaian publik Laporan Penilaian publik Latvi 14-05-2019
Selebaran informasi Selebaran informasi Lituavi 11-11-2022
Karakteristik produk Karakteristik produk Lituavi 11-11-2022
Laporan Penilaian publik Laporan Penilaian publik Lituavi 14-05-2019
Selebaran informasi Selebaran informasi Hungaria 11-11-2022
Karakteristik produk Karakteristik produk Hungaria 11-11-2022
Laporan Penilaian publik Laporan Penilaian publik Hungaria 14-05-2019
Selebaran informasi Selebaran informasi Malta 11-11-2022
Karakteristik produk Karakteristik produk Malta 11-11-2022
Laporan Penilaian publik Laporan Penilaian publik Malta 14-05-2019
Selebaran informasi Selebaran informasi Belanda 11-11-2022
Karakteristik produk Karakteristik produk Belanda 11-11-2022
Laporan Penilaian publik Laporan Penilaian publik Belanda 14-05-2019
Selebaran informasi Selebaran informasi Polski 11-11-2022
Karakteristik produk Karakteristik produk Polski 11-11-2022
Laporan Penilaian publik Laporan Penilaian publik Polski 14-05-2019
Selebaran informasi Selebaran informasi Portugis 11-11-2022
Karakteristik produk Karakteristik produk Portugis 11-11-2022
Laporan Penilaian publik Laporan Penilaian publik Portugis 14-05-2019
Selebaran informasi Selebaran informasi Rumania 11-11-2022
Karakteristik produk Karakteristik produk Rumania 11-11-2022
Laporan Penilaian publik Laporan Penilaian publik Rumania 14-05-2019
Selebaran informasi Selebaran informasi Slovak 11-11-2022
Karakteristik produk Karakteristik produk Slovak 11-11-2022
Laporan Penilaian publik Laporan Penilaian publik Slovak 14-05-2019
Selebaran informasi Selebaran informasi Sloven 11-11-2022
Karakteristik produk Karakteristik produk Sloven 11-11-2022
Laporan Penilaian publik Laporan Penilaian publik Sloven 14-05-2019
Selebaran informasi Selebaran informasi Suomi 11-11-2022
Karakteristik produk Karakteristik produk Suomi 11-11-2022
Laporan Penilaian publik Laporan Penilaian publik Suomi 14-05-2019
Selebaran informasi Selebaran informasi Swedia 11-11-2022
Karakteristik produk Karakteristik produk Swedia 11-11-2022
Laporan Penilaian publik Laporan Penilaian publik Swedia 14-05-2019
Selebaran informasi Selebaran informasi Norwegia 11-11-2022
Karakteristik produk Karakteristik produk Norwegia 11-11-2022
Selebaran informasi Selebaran informasi Islandia 11-11-2022
Karakteristik produk Karakteristik produk Islandia 11-11-2022
Selebaran informasi Selebaran informasi Kroasia 11-11-2022
Karakteristik produk Karakteristik produk Kroasia 11-11-2022
Laporan Penilaian publik Laporan Penilaian publik Kroasia 14-05-2019

Peringatan pencarian terkait dengan produk ini

Lihat riwayat dokumen